Skip to main content
Top
Published in: Virology Journal 1/2017

Open Access 01-12-2017 | Research

Community seroprevalence of hepatitis B, C and human immunodeficiency virus in adult population in gojjam zones, northwest Ethiopia

Authors: Bayeh Abera, Yesuf Adem, Mulat Yimer, Wondemagegn Mulu, Yohannes Zenebe, Zewdie Mekonnen

Published in: Virology Journal | Issue 1/2017

Login to get access

Abstract

Background

In Ethiopia, there is lack of data on the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immune deficiency virus (HIV) infections in adult population at community level. This study aimed at determining the HBV, HCV and HIV seroprevalence in adult population at community level in East and West Gojjam zones in Amhara region, Ethiopia.

Methods

A cross-sectional study was conducted between October 01 and November 30, 2015. The Hepatitis B surface antigen (HBsAg) and anti-HCV were detected using the standard serological tests. The antibody to HIV infection was tested using the national HIV rapid tests algorithms.

Results

A total of 481 adults comprised of 51% females with median age of 25 years took part in the study. Overall, 7.5% (95% CI: 5.5–10.2%) of adult population were infected either with HBV, HCV and HIV. The prevalence of HBV was 15 (3.1%) and for HIV was 16 (3.3%). The seroprevalence of HCV was five (1.0%). HIV-HCV co-infection was found to be two (0.4%). HIV prevalence was higher in non-educated population than their counter parts (P = 0.001). HIV prevalence was high in housewives (6.0%) and merchants (4.7%).

Conclusions

This study revealed an intermediate HBV prevalence and low prevalence of HCV in adult population at community level. HIV prevalence is still a major public health problem in the area. To have the national data, we recommend further study on genotypes of HBV and HCV including local risk factors for transmissions. Moreover, health education on HBV, HCV and HIV transmission should be an intervention measure in the community.
Literature
1.
go back to reference United Nation program on HIV/AIDS. AIDS epidemic update. Switzerland: WHO; 2009. United Nation program on HIV/AIDS. AIDS epidemic update. Switzerland: WHO; 2009.
3.
go back to reference Bane A, Patil A, Khatib M. Healthcare cost and access to care for viral hepatitis in Ethiopia. IJIAS. 2014;9(4):1718–23. Bane A, Patil A, Khatib M. Healthcare cost and access to care for viral hepatitis in Ethiopia. IJIAS. 2014;9(4):1718–23.
5.
go back to reference World Health Organization. Global HIV/AIDS Response – Epidemic update and health sector progress towards universal access-Progress report. 2011. WHO, Geneva. http://www.who.int/. Accessed Jan 2017 World Health Organization. Global HIV/AIDS Response – Epidemic update and health sector progress towards universal access-Progress report. 2011. WHO, Geneva. http://​www.​who.​int/​. Accessed Jan 2017
10.
11.
go back to reference Abate M, Wolde T. Seroprevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis among blood donors at jigjiga blood bank, eastern Ethiopia. Ethiop J Health Sci. 2016;26(2):153–60.CrossRefPubMedPubMedCentral Abate M, Wolde T. Seroprevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis among blood donors at jigjiga blood bank, eastern Ethiopia. Ethiop J Health Sci. 2016;26(2):153–60.CrossRefPubMedPubMedCentral
12.
go back to reference Abera B, Zenebe Y, Mulu W, Kibret M, Kahsu G. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the felgehiwot referral hospital, Ethiopia. BMC Res Notes. 2014;7:838.CrossRefPubMedPubMedCentral Abera B, Zenebe Y, Mulu W, Kibret M, Kahsu G. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the felgehiwot referral hospital, Ethiopia. BMC Res Notes. 2014;7:838.CrossRefPubMedPubMedCentral
13.
go back to reference Molla S, Munshea A, Nibret E. Seroprevalence of hepatitis B surface antigen and anti HCV antibody and its associated risk factors among pregnant women attending maternity ward of felege hiwot referral hospital, northwest Ethiopia: a cross-sectional study. Virol J. 2015;12:204.CrossRefPubMedPubMedCentral Molla S, Munshea A, Nibret E. Seroprevalence of hepatitis B surface antigen and anti HCV antibody and its associated risk factors among pregnant women attending maternity ward of felege hiwot referral hospital, northwest Ethiopia: a cross-sectional study. Virol J. 2015;12:204.CrossRefPubMedPubMedCentral
15.
go back to reference Mulu W, Abera B, Yimer M. Prevalence of human immunodeficiency virus infection and associated factors among students at bahir Dar university. Ethiop J Health Dev. 2014;28(3):170–7. Mulu W, Abera B, Yimer M. Prevalence of human immunodeficiency virus infection and associated factors among students at bahir Dar university. Ethiop J Health Dev. 2014;28(3):170–7.
16.
go back to reference Federal Ministry of Health (FMOH). Country progress report on HIV/AIDS response. Addis Ababa: National HIV/AIDS Prevention and Control office; 2012. Federal Ministry of Health (FMOH). Country progress report on HIV/AIDS response. Addis Ababa: National HIV/AIDS Prevention and Control office; 2012.
17.
go back to reference Hargreaves JR, Glynn JR. Educational attainment and HIV-1 infection in developing countries: a systematic review. Trop Med Int Health. 2002;7:489–98.CrossRefPubMed Hargreaves JR, Glynn JR. Educational attainment and HIV-1 infection in developing countries: a systematic review. Trop Med Int Health. 2002;7:489–98.CrossRefPubMed
19.
go back to reference Daw MA, El-Bouzedi A. Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey. BMC Infect Dis. 2014;14:17.CrossRefPubMedPubMedCentral Daw MA, El-Bouzedi A. Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey. BMC Infect Dis. 2014;14:17.CrossRefPubMedPubMedCentral
20.
go back to reference Birku T, Gelaw B, Moges F, Assefa A. Prevalence of hepatitis B and C viruses infection among military personnel at bahir Dar armed forces general hospital, Ethiopia. BMC Res Notes. 2015;8:737.CrossRefPubMedPubMedCentral Birku T, Gelaw B, Moges F, Assefa A. Prevalence of hepatitis B and C viruses infection among military personnel at bahir Dar armed forces general hospital, Ethiopia. BMC Res Notes. 2015;8:737.CrossRefPubMedPubMedCentral
22.
go back to reference Alemayehu A, Tassachew Y, Sisay Z, Shimelis T. Prevalence and risk factors of hepatitis C among individuals presenting to HIV testing centers, hawassa city, southern Ethiopia. BMC Res Notes. 2011;4:193.CrossRefPubMedPubMedCentral Alemayehu A, Tassachew Y, Sisay Z, Shimelis T. Prevalence and risk factors of hepatitis C among individuals presenting to HIV testing centers, hawassa city, southern Ethiopia. BMC Res Notes. 2011;4:193.CrossRefPubMedPubMedCentral
24.
go back to reference Atsbaha AH, Dejen TA, Belodu R, Getachew K, Saravanan M, Wasihun AG. Sero‑prevalence and associated risk factors for hepatitis C virus infection among voluntary counseling testing and anti retroviral treatment clinic attendants in Adwa hospital, northern Ethiopia. BMC Res Notes. 2016;9:121.CrossRefPubMedPubMedCentral Atsbaha AH, Dejen TA, Belodu R, Getachew K, Saravanan M, Wasihun AG. Sero‑prevalence and associated risk factors for hepatitis C virus infection among voluntary counseling testing and anti retroviral treatment clinic attendants in Adwa hospital, northern Ethiopia. BMC Res Notes. 2016;9:121.CrossRefPubMedPubMedCentral
25.
go back to reference Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among bloo donors at Gondar university teaching hospital, northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010;10:111.CrossRefPubMedPubMedCentral Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among bloo donors at Gondar university teaching hospital, northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010;10:111.CrossRefPubMedPubMedCentral
26.
go back to reference Wondimeneh Y, Alem M, Asfaw F, Belyhun Y. HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among IV positive individuals at university of Gondar teaching hospital, northwest Ethiopia. Virol J. 2013;10:171.CrossRefPubMedPubMedCentral Wondimeneh Y, Alem M, Asfaw F, Belyhun Y. HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among IV positive individuals at university of Gondar teaching hospital, northwest Ethiopia. Virol J. 2013;10:171.CrossRefPubMedPubMedCentral
Metadata
Title
Community seroprevalence of hepatitis B, C and human immunodeficiency virus in adult population in gojjam zones, northwest Ethiopia
Authors
Bayeh Abera
Yesuf Adem
Mulat Yimer
Wondemagegn Mulu
Yohannes Zenebe
Zewdie Mekonnen
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2017
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-017-0696-6

Other articles of this Issue 1/2017

Virology Journal 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.